Bio-Key International Inc (BKYI) Stock: Assessing the Risk and Reward

The stock of Bio-Key International Inc (BKYI) has gone up by 27.27% for the week, with a -15.15% drop in the past month and a -8.94% drop in the past quarter. The volatility ratio for the week is 14.18%, and the volatility levels for the past 30 days are 10.39% for BKYI. The simple moving average for the past 20 days is 10.88% for BKYI’s stock, with a -24.97% simple moving average for the past 200 days.

Is It Worth Investing in Bio-Key International Inc (NASDAQ: BKYI) Right Now?

The 36-month beta value for BKYI is at 0.15. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for BKYI is 2.92M, and currently, shorts hold a 5.23% of that float. The average trading volume for BKYI on December 03, 2024 was 4.93M shares.

BKYI) stock’s latest price update

Bio-Key International Inc (NASDAQ: BKYI)’s stock price has gone rise by 24.44 in comparison to its previous close of 0.90, however, the company has experienced a 27.27% increase in its stock price over the last five trading days. globenewswire.com reported 2024-12-02 that BIO-key (BKYI) & Fiber Food Systems Inc. Collaborate to Enhance Security & Efficiency in Food Tech Sector. Transaction Strengthens BIO-key’s Balance Sheet.

Analysts’ Opinion of BKYI

Many brokerage firms have already submitted their reports for BKYI stocks, with Maxim Group repeating the rating for BKYI by listing it as a “Buy.” The predicted price for BKYI in the upcoming period, according to Maxim Group is $6 based on the research report published on March 26, 2021 of the previous year 2021.

BKYI Trading at 22.69% from the 50-Day Moving Average

After a stumble in the market that brought BKYI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.71% of loss for the given period.

Volatility was left at 10.39%, however, over the last 30 days, the volatility rate increased by 14.18%, as shares sank -9.68% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.66% upper at present.

During the last 5 trading sessions, BKYI rose by +27.27%, which changed the moving average for the period of 200-days by -38.80% in comparison to the 20-day moving average, which settled at $1.0101. In addition, Bio-Key International Inc saw -62.67% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for BKYI

Current profitability levels for the company are sitting at:

  • -1.45 for the present operating margin
  • 0.15 for the gross margin

The net margin for Bio-Key International Inc stands at -1.42. The total capital return value is set at -17.5. Equity return is now at value -527.28, with -112.56 for asset returns.

Based on Bio-Key International Inc (BKYI), the company’s capital structure generated 0.95 points at debt to capital in total, while cash flow to debt ratio is standing at -1.64. The debt to equity ratio resting at 17.97. The interest coverage ratio of the stock is -53.97.

Currently, EBITDA for the company is -7.85 million with net debt to EBITDA at -0.08. When we switch over and look at the enterprise to sales, we see a ratio of 0.65. The receivables turnover for the company is 3.23for trailing twelve months and the total asset turnover is 1.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.78.

Conclusion

In conclusion, Bio-Key International Inc (BKYI) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts